T-cell epitope discovery technologies

Human Immunology

Volumn 75, Issue 6, 2014, Pages 514-519

  Sharma, Govinda ^a,b   Holt, Robert A ^a,b,c  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

Author keywords

Epitopes; High throughput screening; Major histocompatibility complex; T cell receptor

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; T LYMPHOCYTE ANTIGEN; TETRAMER; EPITOPE; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE;

ANTIGEN DETECTION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CELL ASSAY; COMPUTER MODEL; DNA LIBRARY; FLOW CYTOMETRY; GENETIC SCREENING; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEOMICS; REVIEW; T LYMPHOCYTE; CHEMISTRY; GENE LIBRARY; HIGH THROUGHPUT SCREENING; IMMUNOLOGY;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; EPITOPES, T-LYMPHOCYTE; GENE LIBRARY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROARRAY ANALYSIS; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 84900480985     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.03.003     Document Type: Review

References (57)

1. Schreiber R.D., Old L.J., Smyth M.J. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011, 331:1565-1570.
2. Dornmair K., Meinl E., Hohlfeld R. Novel approaches for identifying target antigens of autoreactive human B and T cells. Sem Immunopathol 2009, 31:467-477.
3. Appay V., Doueck D.C., Price D.A. CD8+ T cell efficacy in vaccination and disease. Nat Med 2008, 14:623-628.
4. Davis M.M., Bjorkman P.J. T-cell antigen receptor genes and T-cell recognition. Nature 1988, 334:395-402.
5. Ekeruche-Makinde J., Miles J.J., van den Berg H.A., Skowera A., Cole D.K., Dolton G., et al. Peptide length determines the outcome of TCR/peptide-MHCI engagement. Blood 2013, 121:1112-1123.
6. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 1998, 19:395-404.
7. Woolridge L., Ekereche-Makinde J., van den Berg H.A., Skowera A., Miles J.J., Tan M.P., et al. A single autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem 2012, 287:1168-1177.
8. Sewell A.K. Why must T cells be cross-reactive?. Nat Rev Immunol 2012, 12:669-677.
9. Pentier J.M., Sewell A.K., Miles J.J. Advances in T-cell epitope engineering. Front Immunol 2013, 4:133. 10.3389/fimmu.2013.00133.
10. Buhrman J.D., Jordan K.R., Munson D.J., Moore B.L., Kappler J.W., Slansky J.E. Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor. J Biol Chem 2013, 288:33213-33225.
11. Ekeruche-Makinde J., Clement M., Cole D.K., Edwards E.S., Ladell K., Miles J.J., et al. T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting. J Biol Chem 2012, 287:37269-37281.
12. Chen Y.-T., Scanlan M.J., Sahin U., Tureci O., Gure A.O., Tsang S., et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci 1997, 94:1914-1918.
13. van der Bruggen P., Traversari C., Chomez P., Lurquin C., De Plaen E., Van den Eynde B.J., et al. A gene encoding an antigen recognized by cytolytic T-lymphocytes on a human melanoma. J Immunol 1991, 254:1643-1647.
14. Kawakami Y., Eliyahu S., Delgado C.H., Robbins P.F., Rivoltini L., Topaliani S.L., et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci 1994, 91:3515-3519.
15. Sahin U., Tureci O., Schmitt H., Cochlovius B., Johannes T., Schmits R., et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci 1995, 92:11810-11813.
16. Jager E., Chen Y.-T., Drijfhout J.W., Karbach J., Ringhoffer M., Jager D., et al. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1 - definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 1988, 187:265-270.
17. Falk K., Rotzschke O., Stevanovic S., Jung G., Rammensee H.-G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991, 351:290-296.
18. Cox A.L., Skipper J.S., Chen Y., Henderson R.A., Darrow T.L., Shabanowitz J., et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 1994, 5159:716-719.
19. Karunakaran K.P., Rey-Ladino J., Stoynov N., Berg K., Shen C., Jiang X., et al. Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia. J Immunol 2008, 180:2459-2465.
20. van Haren S.D., Herczenik E., ten Brinke A., Mertens K., Voorberg J., Meijer A.B. HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII. Mol Cell Proteomics 2011, 10:6. 10.1074/mcp.M110.002246.
21. Holcapek M., Jirasko R., Lisa M. Recent developments in liquid chromatography-mass spectrometry and related techniques. J Chromatogr A 2012, 1259:3-15.
22. Peterson J., Purcell A.W., Rossjohn J. Post-translationally modified T cell epitopes: immune recognition and immunotherapy. J Mol Med 2009, 87:1045-1051.
23. Mohammed F., Cobbold M., Zarling A.L., Salim M., Barrett-Wilt G.A., Shabanowitx J., et al. Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self. Nat Immunol 2008, 9:1236-1243.
24. Silva A.M.N., Vitorino R., Domingues M.R.M., Spickett C.M., Domingues P. Post-translational modifications and mass spectrometry detection. Free Radic Biol Med 2013, 65:925-941.
25. Altman J.D., Moss P.A.H., Goulder P.J.R., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996, 5284:94-96.
26. Hadrup S.R., Schumacher T.N. MHC-based detection of antigen-specific CD8+ T cell responses. Cancer Immunol Immunother 2010, 59:1425-1433.
27. Hadrup S.R., Bakker A.H., Shu C.J., Andersen R.S., van Veluw J., Hombrink P., et al. Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat Meth 2009, 6:520-526.
28. Newell E.V., Klein L.O., Yu W., Davis M.M. Simultaneous detection of many T-cell specificities using combinatorial tetramer staining. Nat Meth 2009, 6:497-499.
29. Chattopadhyay P.K., Price D.A., Harper T.F., Betts M.R., Yu J., Gostick E., et al. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nat Med 2006, 12:927-977.
30. Perfetto S.P., Chattopadhyay P.K., Roederer M. Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol 2004, 4:648-655.
31. Newell E.W., Sigal N., Nair N., Kidd B.A., Greenberg H.B., Davis M.M. Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization. Nat Biotechnol 2013, 31:623-629.
32. Soen Y., Chen D.S., Kraft D.L., Davis M.M., Brown P.O. Detection and characterization of cellular immune responses using peptide-MHC microarrays. PLoS Biol 2003, 1:429-438.
33. Stone J.D., Demkowicz W.E., Stern L.J. HLA-restricted epitope identification and detection of functional T cell responses by using MHC-peptide and costimulatory microarrays. Proc Natl Acad Sci 2005, 102:3744-3749.
34. Kwong G.A., Radu C.G., Hwang K., Shu C.J., Ma C., Koya R.C., et al. Modular nucleic acid assembled p/MHC microarrays for multiplexed sorting of antigen-specific T cells. J Am Chem Soc 2009, 131:9695-9703.
35. Deviren G., Gupta K., Paulaitis M.E., Schneck J.P. Detection of antigen-specific T cells on p/MHC microarrays. J Mol Recognit 2007, 20:32-38.
36. Toebes M., Coccoris M., Bins A., Rodenko B., Gomez R., Nieuwkoop N.J., et al. Design and use of conditional MHC class I ligands. Nat Med 2006, 12:246-251.
37. Bakker A.H., Hoppes R., Linnemann C., Toebes M., Rodenko B., Berkers C.R., et al. Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7. Proc Natl Acad Sci 2008, 105:3825-3830.
38. Czerkinsky C.C., Nilsson L.-A., Nygren H., Ouchterlony O., Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Meth 1983, 65:109-121.
39. Carvalho L.H., Hafalla J.C.R., Zavala F. ELISPOT assay to measure antigen-specific murine CD8(+) T cell responses. J Immunol Meth 2001, 252:207-218.
40. Karttunen J., Shastri N. Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene. Proc Natl Acad Sci 1991, 88:3972-3976.
41. Turner M.J., Abdul-Alim S., Willis R.A., Fisher T.L., Lord E.M., Frelinger J.G. T-cell antigen discovery (T-CAD) assay: a novel technique for identifying T cell epitopes. J Immunol Meth 2001, 256:107-119.
42. Siewart K., Malotka J., Kawakami N., Wekerle H., Hohlfeld R., Dornmair K. Unbiased identification of target antigens of CD8+ T cells with combinatorial libraries coding for short peptides. Nat Med 2012, 18:824-827.
43. Valentino M., Frelinger J. An approach to the identification of T cell epitopes in the genomic era: application to Francisella tularensis. Immunol Res 2009, 45:218-228.
44. Valentino M.D., Abdul-Alim C.S., Maben Z.J., Skrombolas D., Hensley L.L., Kawula T.H., et al. A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens. J Immunol Meth 2011, 373:111-126.
45. Crawford F., Jordan K.R., Stadinski B., Wang Y., Huseby E., Marrack P., et al. Use of baculovirus MHC-peptide display libraries to characterize T-cell receptor ligands. Immunol Rev 2006, 210:156-170.
46. Hondowicz B.D., Schwedhelm K.V., Kas A., Tasch M.A., Rawlings C., Ramchurren N., et al. Discovery of T cell antigens by high-throughput screening of synthetic minigene libraries. PLoS One 2012, 7(1):e29949. 10.1371/journal.pone.0029949.
47. Lundegaard C., Lund O., Buus S., Nielsen M. Major histocompatibility complex class I binding predictions as a tool in epitope discovery. Immunology 2010, 130:309-318.
48. Lafuente E.M., Reche P.A. Prediction of MHC-peptide binding - a systematic and comprehensive overview. Curr Pharm Des 2009, 15:3209-3220.
49. Patronov A., Doytchinova I. T-cell epitope vaccine design by immunoinformatics. Open Biol 2013, 3:120139. 10.1098/rsob.120139.
50. Zhang X.W. A combination of epitope prediction and molecular docking allows for good identification of MHC class I restricted T-cell epitopes. Comput Biol Chem 2013, 45:30-35.
51. Vita R., Zarebski L., Greenbaum J.A., Emami H., Hoof I., Salimi N., et al. The immune epitope database 2.0. Nucleic Acids Res 2010, 38:D854-D862.
52. Ma C., Fan R., Ahmad H., Shi Q., Comin-Anduix B., Chodon T., et al. A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells. Nat Med 2011, 17:738-743.
53. Freeman J.D., Warren R.L., Webb J.R., Nelson B.H., Holt R.A. Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing. Genome Res 2009, 19:1817-1824.
54. Warren R.L., Freeman J.D., Zeng T., Choe G., Munro S., Moore R., et al. Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes. Genome Res 2011, 21:790-797.
55. Robins H.S., Srivastava S.K., Campregher P.V., Turtle C.J., Andriesen J., Riddell S.R., et al. Overlap and effective size of the human CD8+ T cell receptor repertoire. Sci Transl Med 2010, 2:47-64. 10.1126/scitranslmed.3001442.
56. Robins H.S., Campregher P.V., Srivastava S.K., Wacher A., Turtle C.J., Kahsai O., et al. Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood 2009, 114:4099-4107.
57. Heemskerk B., Kvistborg P., Schumacher T.N.M. The cancer antigenome. EMBO J. 2013, 32:194-203.